SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FAINARDI, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.257
AS - Asia 6.013
EU - Europa 3.627
SA - Sud America 912
AF - Africa 107
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 10
Totale 22.940
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.057
SG - Singapore 2.538
CN - Cina 1.865
BR - Brasile 786
DE - Germania 633
UA - Ucraina 621
IT - Italia 620
HK - Hong Kong 572
GB - Regno Unito 443
TR - Turchia 392
PL - Polonia 304
VN - Vietnam 293
FI - Finlandia 278
SE - Svezia 196
RU - Federazione Russa 177
CA - Canada 94
MX - Messico 89
ID - Indonesia 81
FR - Francia 73
IN - India 62
ZA - Sudafrica 58
BE - Belgio 55
AT - Austria 50
AR - Argentina 48
JP - Giappone 41
BD - Bangladesh 34
CZ - Repubblica Ceca 33
NL - Olanda 32
ES - Italia 25
LT - Lituania 22
IQ - Iraq 21
EC - Ecuador 20
CO - Colombia 17
IR - Iran 17
MA - Marocco 14
PK - Pakistan 14
PY - Paraguay 14
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 10
NO - Norvegia 9
UY - Uruguay 9
AU - Australia 8
EG - Egitto 8
KE - Kenya 8
PT - Portogallo 8
A2 - ???statistics.table.value.countryCode.A2??? 7
KR - Corea 7
RO - Romania 7
SA - Arabia Saudita 7
VE - Venezuela 7
EU - Europa 6
IE - Irlanda 6
PE - Perù 6
AZ - Azerbaigian 5
BG - Bulgaria 5
CH - Svizzera 5
NP - Nepal 5
PH - Filippine 5
CL - Cile 4
GR - Grecia 4
HN - Honduras 4
IL - Israele 4
KZ - Kazakistan 4
AO - Angola 3
DZ - Algeria 3
ET - Etiopia 3
JM - Giamaica 3
JO - Giordania 3
MY - Malesia 3
NG - Nigeria 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AL - Albania 2
AM - Armenia 2
DO - Repubblica Dominicana 2
GD - Grenada 2
HR - Croazia 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 22.931
Salva come PNG Salva come JPEG
Città #
Singapore 1.351
Woodbridge 1.338
Ashburn 1.277
Fairfield 1.093
Chandler 768
Houston 731
Jacksonville 676
Beijing 626
Santa Clara 614
Hong Kong 572
Ann Arbor 561
Wilmington 395
Seattle 385
Cambridge 360
Warsaw 291
Izmir 234
Los Angeles 225
Nanjing 219
New York 218
Dallas 201
Ferrara 194
Princeton 180
Munich 146
Milan 144
Boardman 122
Shanghai 112
Ho Chi Minh City 104
San Diego 90
Addison 81
Dearborn 80
São Paulo 79
Helsinki 71
Nanchang 67
Turku 66
Mexico City 63
Shenyang 63
Buffalo 62
Bremen 59
Jakarta 59
Hanoi 57
Brussels 55
Brooklyn 53
London 53
The Dalles 52
Tianjin 51
Jiaxing 50
Changsha 46
Chicago 46
Hebei 46
Hefei 43
Tokyo 40
Stockholm 39
Norwalk 38
Montreal 36
Denver 35
Vienna 34
Atlanta 33
Falls Church 32
Poplar 32
Chennai 31
Johannesburg 31
Brno 29
Phoenix 28
San Mateo 28
Toronto 28
Orem 27
Boston 26
Ningbo 26
San Francisco 26
Rio de Janeiro 25
Jinan 24
Orange 23
Redwood City 23
Zhengzhou 23
Ankara 22
Bologna 22
Moscow 22
Auburn Hills 21
Columbus 21
Falkenstein 21
Nuremberg 21
Frankfurt am Main 19
Kunming 19
Rome 19
Guangzhou 18
Mountain View 18
Curitiba 17
Brasília 15
Dong Ket 15
Taizhou 15
Tappahannock 15
Verona 15
Belo Horizonte 14
Charlotte 13
Des Moines 13
Manchester 13
Washington 13
Amsterdam 12
Biên Hòa 12
Hải Dương 12
Totale 15.683
Salva come PNG Salva come JPEG
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 387
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 231
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 216
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 213
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 209
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 206
Evaluation of acute perihematomal regional apparent diffusion coefficient abnormalities by diffusion-weighted imaging 206
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 202
Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up 202
HLA-G Molecules in Autoimmune Diseases and Infections 201
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 198
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 197
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 195
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 194
Alterazioni liquorali nella sindrome di Guillain-Barrè: Utilità nella diagnosi e nel monitoraggio della malattia. 193
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 193
CT perfusion mapping of hemodynamic disturbances associated to acute spontaneous intracerebral hemorrhage 193
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 193
Emerging topics and new perspectives on HLA-G 187
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 185
Spinal anterior epidural hematoma in an elderly man with unrecognized lupic anticoagulant taking warfarin 181
Technical, Anatomical, and Functional Study after Removal of a Symptomatic Cavernous Angioma Located in Deep Wernicke's Territories with Cortico-Subcortical Awake Mapping. 179
Survival prediction in high-grade gliomas using CT perfusion imaging 178
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 178
Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders 178
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 177
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 175
A Further Evidence Of Pathogenic Role Of Chlamydia Pneumoniae In Multiple Sclerosis 170
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients 170
Leptin/adiponectin ratio predicts post-stroke neurological outcome 169
Spontaneous and idiopathic chronic spinal epidural hematoma: two case reports and review of the literature 166
Cerebrospinal fluid analysis and the determination of oligoclonal bands 163
A new developed culture method efficiently supports the growth of Chamydia pneumoniae in PBMC and CSF samples from patients with Multiple Sclerosis 163
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 162
Hyperperfusion syndrome secondary to carotid endovascular rivascularization: a case report 161
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 160
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 160
Cerebrospinal fluid (CSF) Protein Immunoglobulin and cellular abnormalities in Acquired Immune Deficiency Syndrome (AIDS) 159
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 158
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 157
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 155
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 153
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 153
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS 152
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 151
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection 151
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 149
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 148
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 148
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 148
Some basic aspects of HLA-G biology. 148
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 148
Hyperfusion Syndrome Secondary to Carotid Endovascular Rivascularization: a case report 148
Temporal changes in CT perfusion values before and after cranioplasty in patients without symptoms related to external decompression: A pilot study 148
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 147
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 143
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 143
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 143
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 143
Neurofilament ELISA validation 142
New insights into HLA-G and inflammatory diseases 141
25 hydroxyvitamin D in cerebrospinal fluid from patients with multiple sclerosis during relapse and remission 140
Recent advances in our understanding of HLA-G biology: Lessons from a wide spectrum of human diseases 140
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 138
The role of [123I]-FP-CIT SPECT in the diagnosis and clinical menagement of Parkinson's disease 138
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 137
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 136
The incidence of Guillain-Barrè syndrome in Ferrara, Italy: is the disease really increasing? 136
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 134
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 133
Timing of Serum Soluble HLA-G Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage 132
Therapeutic plasma exchange for worsening relapsing remitting multiple sclerosis. A case report 130
Significance of anti-Chlamydophila pneumoniae IgA and IgG determination in patients with acute and post-acute ischaemic stroke 130
Exogenous gangliosides and Guillain-Barre syndrome. An observational study in the Local Health District of Ferrara, Italy 129
Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients 129
Impaired Cerebral Venous Haemodynamics In Multiple Sclerosis Patients 128
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 128
Le catene leggere libere liquorale sclerosi multipla 127
Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms 127
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 124
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 124
Congruence between clinical diagnosis and DATSCAN imaging in 150 consecutive patients. 123
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 123
Role of Toll-like receptors in patients with multiple sclerosis and Chlamydophila pneumoniae infection 122
Effect of HLA-G gene polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 122
Cerebrospinal fluid oligoclonal free light chain profiles in AIDS 121
null 121
Detection of Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response in a subset of patients with progressive forms of multiple sclerosis 120
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 120
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS - ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES. 120
CSF levels and soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis 118
Cerebrospinal fluid free Kappa and Lambda lights chains in MS. A qualitative analysis 117
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 113
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 113
CSF levels of soluble classical HLA-I and non-classical HLA-G molecules in relapsing-remitting multiple sclerosis and their association with CSF IL-10 concentrations and MRI findings. 113
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 112
Chlamydia pneumonia-specific CFS-restricted oligoclonal IgG bands are associated to a subset of patients with prosessive forms of multiple sclerosis. 110
null 110
Inverse association between CSF levels of solubile HLA-G and Fas molecules in MS patients with no evidence of MRI disease activity. 109
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 109
Totale 15.523
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 995
Totale 114.864
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.214 0 0 0 0 0 178 64 221 70 270 283 128
2021/20221.609 84 183 96 51 54 73 76 94 52 143 133 570
2022/20231.809 182 154 69 247 279 237 122 168 208 7 92 44
2023/20241.050 95 107 52 28 110 198 35 89 31 29 24 252
2024/20254.035 103 92 310 158 530 353 98 156 767 477 567 424
2025/20265.779 1.131 456 853 1.429 1.707 203 0 0 0 0 0 0
Totale 23.234